Endocrinologia Clinica - Vilar 6 edicao_Parte708

Prévia do material em texto

8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
Endocrinol (Oxf). 2006; 65:699-705.
Lenders JW, Duh QY, Eisenhofer G et al. Pheochromocytoma and para-ganglioma: an Endocrine Society clinical practice
guideline. J Clin Endocrinol Metab. 2014; 99:1915-42.
Karasek D, Shad U, Frysak Z et al. An update on the genetics of pheochromocytoma. J Hum Hypertens. 2013; 27:141-7.
Toledo RA, Qin Y, Cheng ZM et al. Recurrent mutations of chromatinremodeling genes and kinase receptors in
pheochromocytomas and para-gangliomas. Clin Cancer Res. 2016; 22:2301-10.
Bouloux PMG, Fakeeh M. Investigation of pheocromocytoma. Clin Endocrinol (Oxf). 1995; 43:657-64.
Pappachan JM, Raskauskiene D, Sriraman R et al. Diagnosis and management of pheochromocytoma: a practical guide to
clinicians. Curr Hypertens Rep. 2014; 16:442.
Grossman A, Pacak K, Sawka A et al. Biochemical diagnosis and localization of pheochromocytoma: can we reach a
consensus? Ann N Y Acad Sci. 2006; 1073:332-47.
 Young WF Jr. Endocrine hypertension. In: Melmed S, Polonsky KS, Larsen PR et al. (Ed.). Williams textbook of
endocrinology. 12. ed. Philadelphia: Elsevier Saunders, 2011. p. 545-77.
Fitzgerald PA. Adrenal medulla and paraganglia. In: Gardner DG, Shoback D (Ed.). Greenspan’s basic & clinical
endocrinology. 9. ed. New York: McGraw Hill Co, 2011. p. 345-93.
O’Riordan DS, Young WF Jr, Grant CS et al. Clinical spectrum and outcome of functional extra-adrenal paraganglioma.
World J Surg. 1996; 20:916-21.
Sambaziotis D, Kontogeorgos G, Kovacs K et al. Intrasellar paraganglioma presenting as nonfunctioning pituitary adenoma.
Arch Pathol Lab Med. 1999; 123:429-32.
Wilhelm SM, Prinz RA, Barbu AM et al. Analysis of large versus small pheochromocytomas: operative approaches and
patient outcomes. Surgery. 2006; 140:553-9; discussion 559-60.
Shen WT, Sturgeon C, Clark OH et al. Should pheochromocytoma size influence surgical approach? A comparison of 90
malignant and 60 benign pheochromocytomas. Surgery. 2004; 136:1129-37.
Ahlman H. Malignant phaeochromocytoma. State of the field with future projections. Ann N Y Acad Sci. 2006; 1073:449-
64.
Richard S, Graff J, Lindau J et al. Von Hippel-Lindau disease. Lancet. 2004; 363:1231-4.
Maher ER, Neumann HP, Richard S. Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;
19:617-23.
Barontini M, Dahia PL. VHL disease. Best Pract Res Clin Endocrinol Metab. 2010; 24:401-13.
Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med. 2008; 132:1272-84.
Boedeker CC, Erlic Z, Richard S et al. Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine
neoplasia type 2. J Clin Endocrinol Metab. 2009; 94:1938-44.
Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and
associated hereditary syndromes. Horm Metab Res. 2012; 44:328-33.
Erem C, Onder Ersöz H, Ukinç K et al. Neurofibromatosis type 1 associated with pheochromocytoma: a case report and a
review of the literature. J Endocrinol Invest. 2007; 30:59-64.
Herrera RN, Miotti JA, Fuentes CM et al. Pheochromocytoma associated with von Recklinghausen neurofibromatosis.
Medicina (B Aires). 2007; 67:475-7.
Moline J, Eng C. Multiple endocrine neoplasia type 2: an overview. Genet Med. 2011; 13:755-64.
Qin Y, Yao L, King EE et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet.
2010; 42:229-33.
Abermil N, Guillaud-Bataille M, Burnichon N et al. TMEM127 Screening in a large cohort of patients with
pheochromocytoma and/or paraganglioma. J Clin Endocrinol Metab. 2012; 97:E805-9.
Brenner N, Kopetschke R, Ventz M et al. Cushing’s syndrome due to ACTH-secreting pheochromocytoma. Can J Urol.
2008; 15:3924-7.
Canda AE, Sis B, Sokmen S et al. An unusual mesenteric paraganglioma producing human chorionic gonadotropin. Tumori.
2004; 90:249-52.
Mandel M, Saad F, Andrade FG et al. Paraganglioma produtor de prolactina: relato de dois casos. Arq Bras Endocrinol
Metab. 2003; 47(Suppl 1):S322.
Thomas JE, Rook ED, Kvale WF. The neurologist’s experience with pheochromocytoma: a review of 46 cases. J Urol.
1974; 111:715-21.
Rosas AL, Kasperlik-Zaluska AA, Papierska L et al. Pheochromocytoma crisis induced by glucocorticoids: a report of four
cases and review of the literature. Eur J Endocrinol. 2008; 158:423-9.
Olson SW, Deal LE, Piesman M. Epinephrine-secreting pheochromocytoma presenting with cardiogenic shock and
	Endocrinologia Clinica - Vilar 6 edicao